drugset / Trial / NCT03062774
Continuous Multiple Dose PB-119 Injection in Health Volunteers
SequentialOpen-labelTreatment
Summary
This is an open label, multiple dose study, pharmacokinetic and pharmacodynamics studies will be performed at the same time with tolerability study. Three dose arms are designed, 12 subjects will be enrolled in each arm, will equal number of males and females.
Timeline
- Start
- 2014-11-15
- Primary completion
- 2016-09-13
- Completion
- 2016-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PB-119 | Peptide | 25 ug | Subcutaneous |
| Subject | PB-119 | Peptide | 50 ug | Subcutaneous |
| Subject | PB-119 | Peptide | 100 ug | Subcutaneous |